196 related articles for article (PubMed ID: 30109659)
1. Targeting Phospholipase D Genetically and Pharmacologically for Studying Leukocyte Function.
Gomez-Cambronero J; Ganesan R
Methods Mol Biol; 2018; 1835():297-314. PubMed ID: 30109659
[TBL] [Abstract][Full Text] [Related]
2. PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
Henkels KM; Muppani NR; Gomez-Cambronero J
PLoS One; 2016; 11(11):e0166553. PubMed ID: 27851813
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury.
Abdulnour RE; Howrylak JA; Tavares AH; Douda DN; Henkels KM; Miller TE; Fredenburgh LE; Baron RM; Gomez-Cambronero J; Levy BD
J Leukoc Biol; 2018 May; 103(5):919-932. PubMed ID: 29437245
[TBL] [Abstract][Full Text] [Related]
4. Effects of phospholipase D during cultured osteoblast mineralization and bone formation.
Abdallah D; Skafi N; Hamade E; Borel M; Reibel S; Vitale N; El Jamal A; Bougault C; Laroche N; Vico L; Badran B; Hussein N; Magne D; Buchet R; Brizuela L; Mebarek S
J Cell Biochem; 2019 Apr; 120(4):5923-5935. PubMed ID: 30320913
[TBL] [Abstract][Full Text] [Related]
5. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
Burkhardt U; Beyer S; Klein J
Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis.
Corrotte M; Chasserot-Golaz S; Huang P; Du G; Ktistakis NT; Frohman MA; Vitale N; Bader MF; Grant NJ
Traffic; 2006 Mar; 7(3):365-77. PubMed ID: 16497229
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.
Knapek K; Frondorf K; Post J; Short S; Cox D; Gomez-Cambronero J
Mol Cell Biol; 2010 Sep; 30(18):4492-506. PubMed ID: 20647543
[TBL] [Abstract][Full Text] [Related]
8. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Gomez-Cambronero J
Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
[TBL] [Abstract][Full Text] [Related]
9. Structure and regulation of human phospholipase D.
Bowling FZ; Frohman MA; Airola MV
Adv Biol Regul; 2021 Jan; 79():100783. PubMed ID: 33495125
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.
Kim JH; Lee BD; Kim Y; Lee SD; Suh PG; Ryu SH
J Immunol; 1999 Nov; 163(10):5462-70. PubMed ID: 10553072
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
Stieglitz KA
Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
[TBL] [Abstract][Full Text] [Related]
12. PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils.
Norton LJ; Zhang Q; Saqib KM; Schrewe H; Macura K; Anderson KE; Lindsley CW; Brown HA; Rudge SA; Wakelam MJ
J Cell Sci; 2011 Jun; 124(Pt 12):1973-83. PubMed ID: 21610093
[TBL] [Abstract][Full Text] [Related]
13. Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis.
Gomez-Cambronero J; Di Fulvio M; Knapek K
J Leukoc Biol; 2007 Aug; 82(2):272-81. PubMed ID: 17431093
[TBL] [Abstract][Full Text] [Related]
14. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer.
Gomez-Cambronero J; Shah KN
Handb Exp Pharmacol; 2020; 259():89-113. PubMed ID: 31541319
[TBL] [Abstract][Full Text] [Related]
16. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
Corrotte M; Nyguyen AP; Harlay ML; Vitale N; Bader MF; Grant NJ
J Immunol; 2010 Sep; 185(5):2942-50. PubMed ID: 20679536
[TBL] [Abstract][Full Text] [Related]
17. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
18. Prospects for PLD Inhibition in Cancer and Thrombotic Disease.
Salazar C; Frohman MA
Handb Exp Pharmacol; 2020; 259():79-88. PubMed ID: 31541323
[TBL] [Abstract][Full Text] [Related]
19. PLD1 and PLD2 differentially regulate the balance of macrophage polarization in inflammation and tissue injury.
Hwang WC; Seo SH; Kang M; Kang RH; Di Paolo G; Choi KY; Min DS
J Cell Physiol; 2021 Jul; 236(7):5193-5211. PubMed ID: 33368247
[TBL] [Abstract][Full Text] [Related]
20. The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.
Mateos MV; Kamerbeek CB; Giusto NM; Salvador GA
Int J Biochem Cell Biol; 2014 Oct; 55():119-28. PubMed ID: 25172550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
